Growth Metrics

Biote (BTMD) Common Equity (2021 - 2025)

Biote has reported Common Equity over the past 5 years, most recently at -$50.4 million for Q4 2025.

  • Quarterly results put Common Equity at -$50.4 million for Q4 2025, up 50.69% from a year ago — trailing twelve months through Dec 2025 was -$50.4 million (up 50.69% YoY), and the annual figure for FY2025 was -$50.4 million, up 50.69%.
  • Common Equity for Q4 2025 was -$50.4 million at Biote, up from -$72.8 million in the prior quarter.
  • Over the last five years, Common Equity for BTMD hit a ceiling of $10.7 million in Q1 2022 and a floor of -$141.5 million in Q2 2024.
  • Median Common Equity over the past 5 years was -$64.6 million (2022), compared with a mean of -$57.5 million.
  • Peak annual rise in Common Equity hit 201.52% in 2022, while the deepest fall reached 5136.29% in 2022.
  • Biote's Common Equity stood at $4.1 million in 2021, then tumbled by 1512.7% to -$58.3 million in 2022, then surged by 37.29% to -$36.5 million in 2023, then plummeted by 179.65% to -$102.2 million in 2024, then skyrocketed by 50.69% to -$50.4 million in 2025.
  • The last three reported values for Common Equity were -$50.4 million (Q4 2025), -$72.8 million (Q3 2025), and -$78.8 million (Q2 2025) per Business Quant data.